Peptide Drugs in Gastrointestinal Tumors: Integrating Targeting, Delivery, and Therapeutic Actions for Synergistic Strategies
Biomolecules · 18.03.2026 · 16 (3) · 456
DOI: 10.3390/biom16030456 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 18.03.2026. Verfasst von Qian Ouyang und 10 weiteren Autor:innen. Beteiligte Einrichtung: National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan 430068, China. Hauptthemen laut MEDLINE: Peptides, Gastrointestinal Neoplasms, Antineoplastic Agents, Drug Delivery Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 238 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the National Key R&D Program of China, The Key Cultivation Project of Hubei Province for Science and Technology.
Abstract (Originalsprache)
Gastrointestinal malignant tumors account for approximately one-third of global cancer-related deaths, primarily including colorectal, gastric, pancreatic ductal adenocarcinoma, and hepatocellular carcinomas. These tumors have a high incidence, are often asymptomatic, and are prone to metastasis and recurrence, posing a significant public health burden. Although traditional methods such as radiotherapy and chemotherapy can delay disease progression, their nonspecific effects often lead to severe side effects and drug resistance, resulting in limited efficacy. Therefore, developing novel treatment strategies with high target specificity and favorable biological safety is a critical scientific issue in this field. Peptide drugs offer advantages such as good biocompatibility, low immunogenicity, diverse structures, and ease of modification, collectively demonstrating unique potential for tumor treatment. They can not only achieve precise delivery by specifically recognizing tumor receptors but can also directly interfere with signal transduction, metabolism, and immune regulation, producing multi-target antitumor effects. This article systematically reviews the research progress of peptide drugs in gastrointestinal tumors, focusing on their molecular mechanisms, delivery modification strategies, and the latest applications. It also summarizes the challenges and future directions for clinical translation, providing a theoretical foundation and future perspectives for the precise treatment of gastrointestinal tumors and the design of new drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan 430068, China.
- Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Hubei Key Laboratory of Industrial Microbiology, Hubei University of Technology, Wuhan 430068, China.
- Membrane Protein Disease Research Group, Department of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada.
ORCID-Profile: Qian Ouyang, Qi Zhang, Chaojun Yan, Jingfeng Tang
Förderung
- the National Natural Science Foundation of China
- the National Key R&D Program of China
- The Key Cultivation Project of Hubei Province for Science and Technology
- Doctoral Start-up Foundation of Hubei University of Technology
- National Natural Science Foundation of China
- National Key R&D Program of China
- Key Cultivation Project of Hubei Province for Science and Technology
Zitieren
APA
Ouyang, Q., Wu, G., Chen, A., Zhang, R., Xiao, S., Guo, D., Zhang, Q., Yan, C., Chen, X. Z., Tang, J., & Lyu, H. (2026). Peptide Drugs in Gastrointestinal Tumors: Integrating Targeting, Delivery, and Therapeutic Actions for Synergistic Strategies. Biomolecules, 16(3), 456. https://doi.org/10.3390/biom16030456
Vancouver
Ouyang Q, Wu G, Chen A, Zhang R, Xiao S, Guo D, et al. Peptide Drugs in Gastrointestinal Tumors: Integrating Targeting, Delivery, and Therapeutic Actions for Synergistic Strategies. Biomolecules. 2026;16(3):456. doi:10.3390/biom16030456
BibTeX
@article{Ouyang2026,
author = {Ouyang, Qian and Wu, Guifang and Chen, Anyi and Zhang, Rui and Xiao, Shuai and Guo, Dong and Zhang, Qi and Yan, Chaojun and Chen, Xing-Zhen and Tang, Jingfeng and Lyu, Hao},
title = {Peptide Drugs in Gastrointestinal Tumors: Integrating Targeting, Delivery, and Therapeutic Actions for Synergistic Strategies},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {3},
pages = {456},
doi = {10.3390/biom16030456}
}
EUVIMED